Compare · NNNN vs QCLS
NNNN vs QCLS
Side-by-side comparison of Anbio Biotechnology (NNNN) and Q/C Technologies Inc. (QCLS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NNNN and QCLS operate in Biotechnology: In Vitro & In Vivo Diagnostic Substances (Health Care), so they compete in similar markets.
- NNNN is the larger of the two at $2.48B, about 83.5x QCLS ($29.7M).
- Over the past year, NNNN is up 111.7% and QCLS is down 77.3% - NNNN leads by 189.1 points.
- NNNN has hit the wire 1 time in the past 4 weeks while QCLS has been quiet.
PerformanceNNNN+111.73%QCLS-77.34%
2025-06-09+0.00%2026-06-08
- Company
- Anbio Biotechnology
- Q/C Technologies Inc.
- Price
- $18.23-34.52%
- $3.80+4.11%
- Market cap
- $2.48B
- $29.7M
- 1M return
- -30.41%
- +0.93%
- 1Y return
- +111.73%
- -77.34%
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2014
- News (4w)
- 1
- 0
- Recent ratings
- 0
- 0
Latest NNNN
- SEC Form 6-K filed by Anbio Biotechnology
- SEC Form 6-K filed by Anbio Biotechnology
- Amendment: SEC Form 20-F/A filed by Anbio Biotechnology
- SEC Form 3 filed by new insider Song Suki
- SEC Form 3 filed by new insider Hartzler Nancy
- SEC Form 3 filed by new insider Lau Michael
- SEC Form 3 filed by new insider Tian Chris
- SEC Form 3 filed by new insider Xu Cany
- SEC Form 20-F filed by Anbio Biotechnology
- Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum
Latest QCLS
- SEC Form 10-Q filed by Q/C Technologies Inc.
- Director Voss Chelsea Sierra bought $5,522 worth of shares (1,753 units at $3.15) (SEC Form 4)
- Amendment: SEC Form 10-K/A filed by Q/C Technologies Inc.
- SEC Form 4 filed by White Billy Joe
- SEC Form 4 filed by Friscia Stephen
- SEC Form 4 filed by Voss Chelsea Sierra
- SEC Form 4 filed by Bernstein Bruce
- SEC Form 4 filed by Glass Mitchell
- SEC Form 4 filed by Silverman Joshua
- SEC Form 10-K filed by Q/C Technologies Inc.